Analytical development for complex pharmaceutical formulations Effective analytical development begins with the properties of the active pharmaceutical ingredient (API) and the requirements of its target product profile. The analytical strategy must provide information relevant to the formulation, its intended performance and the stage of development. During pharmaceutical formulation development, analytical methods are used to compare candidate formulations and investigate the effects of changes in composition or processing conditions. For peptides and biologics, this may involve evaluating molecular integrity alongside drug content and formulation performance. The appropriate analytical approach depends on the API, its potential degradation pathways and the characteristics of the delivery system. Key analytical activities in drug delivery development Different formulation technologies require different analytical approaches. A polymer-based microsphere formulation, for example, introduces characterization requirements that differ from those of an injectable gel or solid implant. Analytical activity Development objective API characterization Assessing relevant molecular and physicochemical properties of the active ingredient. Drug content and loading Determining the amount of API incorporated into the formulation. Molecular integrity assessment Investigating potential changes such as aggregation, fragmentation or chemical modification. In vitro release testing Measuring API release over time under defined experimental conditions. Physical characterization Evaluating relevant dosage form attributes, such as particle size, morphology or viscosity. Analytical method development Establishing methods suitable for evaluating relevant quality attributes and development questions. The selection of analytical methods depends on the API, formulation technology and intended use of the resulting data. Not every test is relevant to every development program. Evaluating peptide and biologic stability Peptides and biologics may be sensitive to formulation and processing conditions. Depending on the molecule, exposure to temperature, solvents, mechanical stress or changes in the local chemical environment can influence molecular integrity. Analytical assessment may therefore need to distinguish intact API from degradation products, aggregates or other modified forms. The relevant attributes and methods must be selected according to the molecule and the risks identified during development. For polymer-based sustained-release formulations, stability assessment may extend beyond initial processing and storage. The API can remain within the delivery matrix while its local environment changes through water uptake, swelling or polymer degradation. Evaluating the API during relevant stages of formulation and release testing helps development teams understand whether the selected approach warrants further investigation. In vitro release testing for long-acting injectables In vitro release testing is an important part of long-acting injectable development. It provides information about how an API is released from its delivery system over time under defined laboratory conditions. For polymer-based systems, the observed release profile may reflect the combined effects of diffusion, water uptake, swelling and polymer degradation. Drug loading, API distribution and dosage form structure can also influence release behavior. Analytical methods must be appropriate for the intended release study, including the relevant sampling intervals, expected API concentrations and potential changes in molecular integrity. Release testing can help compare candidate formulations, investigate changes in release behavior and assess reproducibility. However, an in vitro release profile does not automatically establish in vivo performance. The relationship between laboratory results and behavior after administration requires product-specific investigation. Discuss your analytical development requirements Contact Innocore Analytical method development and suitability An analytical method must be capable of generating information that supports the decisions being made during development. The required method characteristics depend on the API, sample matrix, analyte concentration and intended application. For example, measuring API content in a polymer-based formulation may require sample preparation that separates or extracts the API from the delivery matrix. The analytical procedure must be evaluated to determine whether the preparation and measurement steps are suitable for the intended purpose. Methods used to assess molecular integrity may require different analytical principles from those used to measure drug loading or physical formulation characteristics. As development progresses, analytical methods may require further qualification or validation according to their intended use and the applicable development and regulatory requirements. Method development, qualification and validation are distinct activities and should not be treated as interchangeable. Supporting formulation and process development Analytical results provide a basis for understanding how changes in formulation composition and manufacturing conditions affect product quality. During process development, analytical testing can help investigate relationships between processing parameters and critical quality attributes. For example, changes in microsphere manufacturing conditions may affect particle size distribution, API loading or release behavior. These findings support process optimization and help identify which attributes require continued evaluation as the formulation progresses. Analytical knowledge also contributes to technology transfer, where methods, sample preparation procedures and relevant development findings may need to be transferred to a receiving laboratory or manufacturing environment. Integrated analytical development at Innocore Analytical development is closely connected to formulation science, polymer behavior and manufacturing requirements. For complex sustained-release systems, evaluating these elements together can help clarify the effects of formulation and process changes. Innocore combines analytical development with its polymer-based drug delivery expertise and broader CDMO services. This allows analytical questions to be considered within the context of the molecule, dosage form and intended development stage. The analytical strategy is defined around the technical requirements of each program rather than applying the same methods to every API or formulation. Frequently asked questions about analytical development What is pharmaceutical analytical development? + Pharmaceutical analytical development involves establishing methods to characterize an API, formulation and relevant quality attributes. These methods support development decisions, formulation comparisons and the evaluation of product quality. Why is analytical development important for peptides and biologics? + Peptides and biologics may undergo changes in molecular integrity during processing, storage or release. Appropriate analytical methods help investigate these changes and assess relevant quality attributes. What is the purpose of in vitro release testing? + In vitro release testing measures API release from a formulation over time under defined laboratory conditions. It can support formulation comparison, release characterization and development decisions. What is the difference between analytical method development and validation? + Method development establishes an analytical procedure suitable for its intended purpose. Validation provides documented evidence that a method meets defined performance requirements for a specified application. Discuss your analytical development requirements Analytical development requires methods suited to the API, formulation technology and questions being investigated. Innocore supports pharmaceutical and biotechnology companies developing polymer-based sustained-release formulations for peptides and biologics. Contact Innocore to discuss the analytical requirements and characterization challenges of your development program. Contact Innocore